These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25400950)

  • 21. Underestimation of invasive lesions in patients with ductal carcinoma in situ of the breast diagnosed by ultrasound-guided biopsy: a comparison between patients with and without HER2/neu overexpression.
    Chang WC; Hsu HH; Yu JC; Ko KH; Peng YJ; Tung HJ; Chang TH; Hsu GC
    Eur J Radiol; 2014 Jun; 83(6):935-941. PubMed ID: 24666513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rates of presurgical underestimation of breast cancer after standardized assessment of breast calcifications.
    Timpe L; Berkemeyer S; Puesken M; Tio J; Heindel W; Weigel S
    Rofo; 2015 Jun; 187(6):445-9. PubMed ID: 25877994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammographic features are associated with clinicopathological characteristics in invasive breast cancer.
    Jiang L; Ma T; Moran MS; Kong X; Li X; Haffty BG; Yang Q
    Anticancer Res; 2011 Jun; 31(6):2327-34. PubMed ID: 21737659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation.
    Hermann G; Keller RJ; Drossman S; Caravella BA; Tartter P; Panetta RA; Bleiweiss IJ
    Can Assoc Radiol J; 1999 Aug; 50(4):235-40. PubMed ID: 10459309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonpalpable breast cancer: mammographic appearance as predictor of histologic type.
    Thurfjell MG; Lindgren A; Thurfjell E
    Radiology; 2002 Jan; 222(1):165-70. PubMed ID: 11756721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of ultrasound and sonographically guided core biopsy in the diagnostic evaluation of ductal carcinoma in situ (DCIS) of the breast.
    Londero V; Zuiani C; Furlan A; Nori J; Bazzocchi M
    Radiol Med; 2007 Sep; 112(6):863-76. PubMed ID: 17891529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a correlation between breast cancer molecular subtype using receptors as surrogates and mammographic appearance?
    Killelea BK; Chagpar AB; Bishop J; Horowitz NR; Christy C; Tsangaris T; Raghu M; Lannin DR
    Ann Surg Oncol; 2013 Oct; 20(10):3247-53. PubMed ID: 23975299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
    Stomper PC; Geradts J; Edge SB; Levine EG
    AJR Am J Roentgenol; 2003 Dec; 181(6):1679-84. PubMed ID: 14627596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
    Van Bockstal M; Baldewijns M; Colpaert C; Dano H; Floris G; Galant C; Lambein K; Peeters D; Van Renterghem S; Van Rompuy AS; Verbeke S; Verschuere S; Van Dorpe J
    Histopathology; 2018 Dec; 73(6):923-932. PubMed ID: 30168167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative estrogen-receptor invasive breast carcinoma: mammographic aspects, correlations with HER2/neu oncoprotein status.
    Enache DE; Georgescu CV; Pătrană N
    Rom J Morphol Embryol; 2012; 53(3 Suppl):755-62. PubMed ID: 23188436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.
    Van Bockstal M; Lambein K; Gevaert O; De Wever O; Praet M; Cocquyt V; Van den Broecke R; Braems G; Denys H; Libbrecht L
    Histopathology; 2013 Oct; 63(4):520-33. PubMed ID: 23889174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasonography as adjunct to mammography in the evaluation of breast tumors.
    Skaane P
    Acta Radiol Suppl; 1999; 420():1-47. PubMed ID: 10693544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elastic stains in the evaluation of DCIS with comedo necrosis in breast cancers.
    Zombori T; Cserni G
    Virchows Arch; 2018 Jun; 472(6):1007-1014. PubMed ID: 29101458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasonographic detection and characterization of asymptomatic ductal carcinoma in situ with histopathologic correlation.
    Gwak YJ; Kim HJ; Kwak JY; Lee SK; Shin KM; Lee HJ; Kim GC; Jang YJ; Han MH; Park JY; Jung JH
    Acta Radiol; 2011 May; 52(4):364-71. PubMed ID: 21498298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-grade histologic features of DCIS are associated with R5 rather than R3 calcifications in breast screening mammography.
    Hayes BD; Brodie C; O'Doherty A; Quinn CM
    Breast J; 2013; 19(3):319-24. PubMed ID: 23600490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
    Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
    Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
    Ioachim E; Charchanti A; Briasoulis E; Karavasilis V; Tsanou H; Arvanitis DL; Agnantis NJ; Pavlidis N
    Eur J Cancer; 2002 Dec; 38(18):2362-70. PubMed ID: 12460779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammographic and ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes.
    Kim MY; Choi N
    Acta Radiol; 2013 Oct; 54(8):889-94. PubMed ID: 23761558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.